Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA panel to weigh heart safety of Novo's new insulin
FDA panel to weigh heart safety of Novo's new insulin
FDA panel to weigh heart safety of Novo's new insulin
Submitted by
admin
on October 25, 2012 - 5:33pm
Source:
Reuters
News Tags:
advisory panels
FDA
Novo Nordisk
insulin
diabetes
degludec
Headline:
FDA panel to weigh heart safety of Novo's new insulin
Do Not Allow Advertisers to Use My Personal information
